Recent News

• 11.05.2026 - Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
• 11.05.2026 - Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
• 11.05.2026 - Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
• 11.04.2026 - Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.04.2026 - Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.04.2026 - Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 11.03.2026 - Cabaletta Bio to Participate in Upcoming Investor Conferences
• 11.03.2026 - Cabaletta Bio to Participate in Upcoming Investor Conferences
• 11.03.2026 - Cabaletta Bio to Participate in Upcoming Investor Conferences
• 10.05.2026 - Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 11.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2026 - 8-K Current report
• 11.05.2026 - EX-99.1 EX-99.1
• 10.30.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 09.14.2026 - 8-K Current report
• 08.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors